{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:55Z","timestamp":1789448575782,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Von Hippel-Lindau disease is a rare autosomal dominant genetic disorder caused by mutations in the\n                    <jats:italic>VHL<\/jats:italic>\n                    tumor suppressor gene located on chromosome 3. Its core feature is the development of vascular-rich tumors or cysts in multiple organ systems at different ages, mainly manifesting as cerebellar hemangioblastoma, retinal hemangioblastoma, renal cell carcinoma and\/or multiple renal cysts, and adrenal pheochromocytoma, among others. The disease is rare and involves multiple systems, making diagnosis challenging. Genetic testing has gradually become the gold standard for its diagnosis. This case report describes a 54-year-old male patient who presented with an intracranial space-occupying lesion detected during a health check-up three years earlier, as well as headache, dizziness, and decreased vision for more than four months. Imaging and pathological examinations ultimately confirmed a diagnosis of VHL syndrome, complicated by a rare \u201ccollision tumor\u201d composed of an intracranial (lateral ventricular) hemangioblastoma and metastatic clear cell renal cell carcinoma. After resection of the lateral ventricular tumor, the patient developed extensive intracranial hemorrhage and fatal brainstem hemorrhage due to the inherently high vascularity of the hemangioblastoma, and eventually died. Through this complex and high-risk case, we discuss the diagnostic difficulties of VHL syndrome, the surgical risks of central nervous system lesions, and multidisciplinary management strategies, aiming to provide practical guidance for clinical practice.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1899311","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:26:52Z","timestamp":1789446412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Von Hippel-Lindau syndrome presenting as a lateral ventricular space-occupying lesion: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Lu","family":"Liu","sequence":"first","affiliation":[{"name":"The First College of Clinical Medical Science, China Three Gorges University","place":["Yichang, China"]},{"name":"Department of Critical Care Medicine, Yichang Central People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Chen","sequence":"additional","affiliation":[{"name":"The First College of Clinical Medical Science, China Three Gorges University","place":["Yichang, China"]},{"name":"Department of Critical Care Medicine, Yichang Central People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Yichang Central People\u2019s Hospital","place":["Yichang, China"]},{"name":"Critical Care Medicine Laboratory, Yichang Sepsis Clinical Research Center","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Laboratory of Critical Care Medicine, Zhongnan Hospital, Hubei Provincial Clinical Research Center for Critical Care Medicine (Sepsis Research Collaborative Unit)","place":["Yichang, China"]},{"name":"Department of Medical Administration, Yichang Central People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"Von hippel-lindau disease","volume":"361","author":"Lonser","year":""},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162480","article-title":"Von hippel-lindau disease: insights into oxygen sensing, protein degradation, and cancer","volume":"132","author":"Kaelin","year":"2022","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2023.11.003","article-title":"Von hippel\u2013lindau disease-related neoplasia with an emphasis on renal manifestations","volume":"41","author":"Tekin","year":"2024","journal-title":"Semin Diagn Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3171\/2014.1.JNS131431","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von hippel-lindau disease: clinical article","volume":"120","author":"Lonser","year":"2014","journal-title":"J Neurosurg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jamaneurol.2017.4469","article-title":"Review of the neurological implications of von hippel\u2013lindau disease","volume":"75","author":"Dornbos","year":"2018","journal-title":"JAMA Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von hippel\u2013lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.15586\/jkc.v12i3.396","article-title":"Narrative review of von hippel-lindau syndrome: from discovery to modern medical and surgical therapies","volume":"12","author":"Coco","year":""},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eururo.2025.03.002","article-title":"Longitudinal evaluation of clear-cell renal cell carcinoma in von hippel-lindau disease","volume":"88","author":"Linehan","year":"2025","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.iae.0000244659.62202.ee","article-title":"Molecular pathology of eyes with von hippel-lindau (VHL) disease: a review","volume":"27","author":"Chan","year":"2007","journal-title":"Retina (Philadelphia Pa)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejca.2022.12.011","article-title":"The road to systemic therapy in von hippel-lindau (VHL) disease: are we there yet","volume":"182","author":"Shepherd","year":"2023","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1586\/ern.11.124","article-title":"Management of von hippel-lindau disease-associated CNS lesions","volume":"11","author":"Wind","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf041","article-title":"Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and von hippel\u2013lindau disease: a multicenter study","volume":"27","author":"Wach","year":"2025","journal-title":"Neuro-Oncology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2022.10.042","article-title":"Perioperative surgical risks in patients with hemangioblastomas: a retrospective nationwide review in Japan","volume":"170","author":"Hidaka","year":"2023","journal-title":"World Neurosurg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-36084-8_14","article-title":"VHL: trends and insight into a multi-modality, interdisciplinary approach for management of central nervous system hemangioblastoma","volume":"135","author":"Matloob","year":"2023","journal-title":"Acta Neurochirurgica Supplement"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00389-9","article-title":"Belzutifan for patients with von hippel-lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study","volume":"25","author":"Iliopoulos","year":"2024","journal-title":"Lancet Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00099-3","article-title":"Belzutifan for von hippel-lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study","volume":"26","author":"Srinivasan","year":"2025","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/tau-2025-637","article-title":"From surgery to systemic therapy in von hippel-lindau disease: insights from extended follow-up of LITESPARK-004","volume":"14","author":"Tachiki","year":"2025","journal-title":"Trans Andrology Urol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.15586\/jkcvhl.v11i4.355","article-title":"Relationship between ZHX2 expression and VHL gene alteration in VHL-associated and sporadic hemangioblastomas of the central nervous system","volume":"11","author":"Kanno","year":"2024","journal-title":"J Kidney Cancer VHL"},{"key":"B20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10143-025-03454-9","article-title":"Stereotactic radiosurgery in the management of central nervous system hemangioblastomas: a systematic review and meta-analysis","volume":"48","author":"Zare","year":"2025","journal-title":"Neurosurgical Rev"},{"key":"B21","article-title":"Belzutifan for treating tumours associated with von hippel-lindau disease","volume-title":"National Institute for Health and Care Excellence: Technology Appraisals","year":""}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1899311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:26:53Z","timestamp":1789446413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1899311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1899311"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1899311","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1899311"}}